|
|
|
|
||
Re: Sangamo and Shire Restructure Collaboration to Accelerate Development of ZFP Therapeutics(R) for the Treatment of Hemophilia and Huntington's DiseaseEd explained this on the call - if they want to do a deal with someone else, they have to give Shire an opportunity to make an offer first. If the offer (in aggregate) winds up not being as good as the one they get from another party, the other party wins. |
return to message board, top of board |